+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Blister Pack Vision Inspection Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 170 Pages
  • November 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6294930
The blister pack vision inspection systems market size is expected to grow from USD 498.14 million in 2025 to USD 528.61 million in 2026 and is forecast to reach USD 724.92 million by 2031 at 6.52% CAGR over 2026-2031. This report is Segmented by Inspection Type (Tablet and Capsule Inspection, and More), Deployment (Inline, Standalone, and More), Inspection Stage (Product Filling Inspection, and More), Technology (2D Vision, 3 D Vision, and More) Automation Level (Fully Automatic Systems, and More), End-User (CMOs/CDMOs, and More), and Geography. The Market Forecasts are in Terms of Value (USD).

Global Blister Pack Vision Inspection Systems Market Trends and Insights

Stricter Pharmaceutical Packaging Validation Is Redefining Inspection as a Regulatory Necessity

Regulatory expectations have shifted blister inspection from an operating choice to a compliance requirement. The FDA published draft guidance on container closure systems on August 14, 2026. The guidance uses a risk-based framework for packaging components, including blister films and lidding foils. It calls for evidence on seal integrity, barrier performance, and material compatibility in drug applications and supplements. Under 21 CFR Part 211, packaging and labeling controls require written procedures and examination of packaging materials. These obligations support demand in the blister pack vision inspection systems market for validated equipment and electronic inspection records.

High-Speed Solid-Dose Production Expansion Outpaces Manual Inspection Capacity

Higher solid-dose output is increasing the need for automated inspection at commercial packaging sites. Aenova made a substantial investment at its Bad Aibling blister packaging center, adding an additional high-speed blister line and significantly increasing the site’s annual blister production capacity. Adare completed its Milan packaging expansion in October 2025 with a Marchesini Integra 220S MA260 blister line. The line includes SEA Vision serialization capabilities and supports annual blister output above 50 million units. These projects show why high-speed output is supporting investment across the blister pack vision inspection systems market.

High Validation and Integration Costs Cap Adoption Velocity Across All Market Tiers

The cost of deploying a vision system extends beyond the equipment purchase. Pharmaceutical facilities must manage installation qualification, operational qualification, performance qualification, software documentation, and training. Existing PLC infrastructure may also require modernization before new inspection software can be validated. A case study by E Tech Group describes a blister-line upgrade that required PLC communication improvements, machine vision integration, and SCADA audit trails for 21 CFR Part 11 compliance. These activities can delay the commercial return from a new line. They are a material constraint for smaller manufacturers and regional CMOs.

Other drivers and restraints analyzed in the detailed report include:

  1. The Shift From Manual Sampling to Documented Inline Inspection Changes Quality-System Logic
  2. AI-Based Defect Classification With Small Training Sets Unlocks Coverage Beyond Rule-Based Platforms
  3. Capital Sensitivity in Generic-Drug Plants Creates Prolonged Replacement Cycles

Segment Analysis

Tablet and capsule inspection held 29.94% of the blister pack vision inspection systems market share in 2025. Oral solid dosage forms continue to generate the largest base of unit-level blister inspection demand. Print and code inspection is projected to expand at a 6.88% CAGR through 2031. The category benefits from serialized code verification on pharmaceutical packs. The U.S. DSCSA requires interoperable tracing and verification of certain prescription drug products at the package level. The European delegated regulation requires safety features and verification arrangements for medicinal products. These rules reinforce the case for print quality and code-readability checks on blister lines. The blister pack vision inspection systems market supports this need through vision, OCR, and verification functions. Manufacturers also use these systems to maintain reliable records when products move across regulated supply chains.

Blister cavity and forming inspection focus on defects in the forming film before product packing is complete. Seal and foil inspection identifies incomplete seals and lidding anomalies that can affect package protection. These functions address physical integrity instead of identification data alone. Foreign-particle and contamination inspection has greater relevance on multi-product lines with elevated cross-contamination exposure. Tamper-evident seal checks and label verification provide additional controls where local documentation requirements are increasing. ISO 11607 describes packaging requirements for terminally sterilized medical devices, though its direct scope differs from pharmaceutical blister packaging. Inspection suppliers can apply related packaging-control practices where they suit the product and facility. The broader mix of checks allows a single platform to support both product protection and traceability. This creates opportunities for integrated inspection configurations rather than single-purpose cameras.

Inline and integrated systems accounted for 72.33% of the blister pack vision inspection systems market size in 2025. Their leading position reflects the long-standing use of real-time inspection on validated commercial blister lines. Retrofit systems are projected to expand at a 7.48% CAGR through 2031. They offer an alternative for asset owners that require stronger records but cannot justify replacing the entire packaging line. A retrofit can combine camera stations, controlled lighting, OCR modules, and optical character verification functions. It can also connect to existing reject mechanisms and line controls. This approach limits changes to the production architecture. It can reduce downtime during the upgrade process. It also supports sites that need to improve compliance while preserving existing equipment.

Standalone and offline systems remain useful for quality laboratories and short production campaigns. These systems suit specialty products where continuous inline integration would not be cost-effective. Their role remains narrower than inline inspection at a commercial scale. CDMOs are increasingly standardizing processes across several customer products and packaging formats. This supports greater use of inline systems for recurring commercial work. Retrofit demand remains important because producers are also funding capacity for GLP-1 medicines and biologics. Capital constraints can make a validated upgrade more attractive than a new equipment authorization. The blister pack vision inspection systems market therefore includes both embedded line systems and lower-disruption upgrade options. The choice depends on installed assets, qualification requirements, and expected production volumes.

Complete Report Scope:

  • By Inspection Type
    • Tablet and Capsule Inspection
    • Blister Cavity and Forming Inspection
    • Seal and Foil Inspection
    • Print and Code Inspection
    • Foreign Particle and Contamination Inspection
    • Other Inspection Types
  • By Deployment
    • Inline / Integrated
    • Standalone / Offline
    • Retrofit Systems
  • By Inspection Stage
    • Forming / Pre-Filling Inspection
    • Product Filling Inspection
    • Sealing / Lidding Inspection
    • Post-Sealing Inspection
    • Final Pack / Outfeed Inspection
  • By Technology
    • 2D Vision Inspection
    • 3D Vision Inspection
    • Multimodal Vision Inspection
    • AI-Enabled Vision Inspection
  • By Automation Level
    • Fully Automatic Systems
    • Semi-Automatic Systems
    • Manual Inspection Systems
  • By End-User
    • Pharmaceutical Manufacturers
    • Contract Manufacturing Organizations (CMOs/CDMOs)
    • OTC and Nutraceutical Manufacturers
    • Other End-Users
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • ASEAN
      • Rest of Asia-Pacific
    • Middle East and Africa
      • Middle East
        • Saudi Arabia
        • Turkey
        • United Arab Emirates
        • Rest of the Middle East
      • Africa
        • South Africa
        • Nigeria
        • Rest of Africa

Geography Analysis

North America held 30.41% of the blister pack vision inspection systems market share in 2025. The region benefits from FDA oversight and a significant base of commercial pharmaceutical packaging capacity. The DSCSA requires interoperable electronic tracing and verification for covered prescription drug products. This requirement supports spending on print and code inspection for serialized packs. Canada and Mexico also contribute through export-oriented generic manufacturing that must meet U.S. regulatory requirements. The regional opportunity, therefore, extends across manufacturing supply chains linked to the United States.

Asia-Pacific is projected to expand at a 7.44% CAGR through 2031. Export-quality requirements, local regulatory changes, and capacity additions support this position. Anritsu launched the Ariphas transmission near-infrared tablet inspection device in Japan in February 2026. The system provides non-destructive inspection of tablet interiors, including ingredient uniformity deviations and mixed-tablet contamination. India and China face quality requirements from Western customers and regulators. South Korea and ASEAN countries are also adoption centers for producers seeking European GMP-compliant documentation. Japan also faces a material-transition cycle that could require inspection-system requalification on blister lines.

Europe has a material presence in the blister pack vision inspection systems market because of its established pharmaceutical manufacturing and compliance systems. The EU FMD framework requires safety features and verification processes for medicinal products. Germany, Italy, and France remain important national markets for production equipment and inspection systems. Syntegon launched the AIM9 high-speed inspection platform in February 2026 for visual inspection and container closure integrity testing. South America and the Middle East and Africa remain earlier-stage areas, but domestic pharmaceutical investment can create greenfield demand.



List of Companies Covered in this Report:

  1. Antares Vision Group
  2. SEA Vision S.r.l.
  3. Cognex Corporation
  4. KEYENCE CORPORATION
  5. Mettler-Toledo International Inc.
  6. Omron Corporation
  7. Syntegon Technology GmbH
  8. Korber AG
  9. Jekson Vision
  10. Viswill Co., Ltd.
  11. Heuft Systemtechnik GmbH
  12. Packaging Technologies and Inspection
  13. ACG Group
  14. Optel Group
  15. Laetus GmbH
  16. Scanware Electronic GmbH
  17. Kevision Systems Pvt. Ltd.
  18. SICK AG
  19. Basler AG
  20. Teledyne Technologies Incorporated
  21. Zebra Technologies Corporation
  22. Ishida Co., Ltd.
  23. MinebeaMitsumi Inc.
  24. Pharmaworks, Inc.
  25. Optimal Industrial Automation and Technologies

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Stricter Pharmaceutical Packaging Validation
4.2.2 Expansion of High-Speed Solid-Dose Production
4.2.3 Shift From Manual Sampling to Documented Inline Inspection
4.2.4 Serialization and Traceability Integration
4.2.5 AI-Based Defect Classification With Small Training Sets
4.2.6 Retrofit Demand From Legacy Blister Lines
4.3 Market Restraints
4.3.1 High Validation and Integration Costs
4.3.2 Capital Sensitivity in Generic-Drug Plants
4.3.3 False Rejects From Foil Glare and Transparent Cavities
4.3.4 Revalidation Burden After Format or Material Changes
4.4 Industry Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By Inspection Type
5.1.1 Tablet and Capsule Inspection
5.1.2 Blister Cavity and Forming Inspection
5.1.3 Seal and Foil Inspection
5.1.4 Print and Code Inspection
5.1.5 Foreign Particle and Contamination Inspection
5.1.6 Other Inspection Types
5.2 By Deployment
5.2.1 Inline / Integrated
5.2.2 Standalone / Offline
5.2.3 Retrofit Systems
5.3 By Inspection Stage
5.3.1 Forming / Pre-Filling Inspection
5.3.2 Product Filling Inspection
5.3.3 Sealing / Lidding Inspection
5.3.4 Post-Sealing Inspection
5.3.5 Final Pack / Outfeed Inspection
5.4 By Technology
5.4.1 2D Vision Inspection
5.4.2 3D Vision Inspection
5.4.3 Multimodal Vision Inspection
5.4.4 AI-Enabled Vision Inspection
5.5 By Automation Level
5.5.1 Fully Automatic Systems
5.5.2 Semi-Automatic Systems
5.5.3 Manual Inspection Systems
5.6 By End-User
5.6.1 Pharmaceutical Manufacturers
5.6.2 Contract Manufacturing Organizations (CMOs/CDMOs)
5.6.3 OTC and Nutraceutical Manufacturers
5.6.4 Other End-Users
5.7 By Geography
5.7.1 North America
5.7.1.1 United States
5.7.1.2 Canada
5.7.1.3 Mexico
5.7.2 South America
5.7.2.1 Brazil
5.7.2.2 Argentina
5.7.2.3 Rest of South America
5.7.3 Europe
5.7.3.1 Germany
5.7.3.2 United Kingdom
5.7.3.3 France
5.7.3.4 Italy
5.7.3.5 Spain
5.7.3.6 Rest of Europe
5.7.4 Asia-Pacific
5.7.4.1 China
5.7.4.2 Japan
5.7.4.3 India
5.7.4.4 South Korea
5.7.4.5 ASEAN
5.7.4.6 Rest of Asia-Pacific
5.7.5 Middle East and Africa
5.7.5.1 Middle East
5.7.5.1.1 Saudi Arabia
5.7.5.1.2 Turkey
5.7.5.1.3 United Arab Emirates
5.7.5.1.4 Rest of the Middle East
5.7.5.2 Africa
5.7.5.2.1 South Africa
5.7.5.2.2 Nigeria
5.7.5.2.3 Rest of Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
6.4.1 Antares Vision Group
6.4.2 SEA Vision S.r.l.
6.4.3 Cognex Corporation
6.4.4 KEYENCE CORPORATION
6.4.5 Mettler-Toledo International Inc.
6.4.6 Omron Corporation
6.4.7 Syntegon Technology GmbH
6.4.8 Korber AG
6.4.9 Jekson Vision
6.4.10 Viswill Co., Ltd.
6.4.11 Heuft Systemtechnik GmbH
6.4.12 Packaging Technologies and Inspection
6.4.13 ACG Group
6.4.14 Optel Group
6.4.15 Laetus GmbH
6.4.16 Scanware Electronic GmbH
6.4.17 Kevision Systems Pvt. Ltd.
6.4.18 SICK AG
6.4.19 Basler AG
6.4.20 Teledyne Technologies Incorporated
6.4.21 Zebra Technologies Corporation
6.4.22 Ishida Co., Ltd.
6.4.23 MinebeaMitsumi Inc.
6.4.24 Pharmaworks, Inc.
6.4.25 Optimal Industrial Automation and Technologies
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-Space and Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Antares Vision Group
  • SEA Vision S.r.l.
  • Cognex Corporation
  • KEYENCE CORPORATION
  • Mettler-Toledo International Inc.
  • Omron Corporation
  • Syntegon Technology GmbH
  • Korber AG
  • Jekson Vision
  • Viswill Co., Ltd.
  • Heuft Systemtechnik GmbH
  • Packaging Technologies and Inspection
  • ACG Group
  • Optel Group
  • Laetus GmbH
  • Scanware Electronic GmbH
  • Kevision Systems Pvt. Ltd.
  • SICK AG
  • Basler AG
  • Teledyne Technologies Incorporated
  • Zebra Technologies Corporation
  • Ishida Co., Ltd.
  • MinebeaMitsumi Inc.
  • Pharmaworks, Inc.
  • Optimal Industrial Automation and Technologies